Secomycalolide A: A New Proteasome Inhibitor Isolated from a Marine Sponge of the Genus Mycale

Marine Drugs - Tập 3 Số 2 - Trang 29-35
Sachiko Tsukamoto1, Keiichirou Koimaru1, Tomihisa Ohta1
1Graduate School of Natural Science and Technology, Kanazawa University, Kakuma-machi, Kanazawa 920-1192, Japan

Tóm tắt

A new oxazole-containing proteasome inhibitor, secomycalolide A, together with known mycalolide A and 30-hydroxymycalolide A, was isolated from a marine sponge of the genus Mycale. They showed proteasome inhibitory activities with IC50 values of 11-45 μg/mL.

Từ khóa


Tài liệu tham khảo

Fusetani, 1989, Mycalolides A-C, Hybrid Macrolides of Ulapualides and Halichondramide, from a Sponge of the Genus Mycale, Tetrahedron Lett, 30, 2809, 10.1016/S0040-4039(00)99131-7

Matsunaga, 1998, New Mycalolides from the Marine Sponge Mycale magellanica and Their Interconversion, J. Nat. Prod, 61, 1164, 10.1021/np980102r

Phuwapraisirisan, 2002, Isolation of a New Mycalolide from the Marine Sponge Mycale izuensis, J. Nat. Prod., 65, 942, 10.1021/np010663+

Rashid, 1995, Mycalolides D and E, New Cytotoxic Macrolides from a Collection of the Stony Coral Tubastrea faulkneri, J. Nat. Prod, 58, 1120, 10.1021/np50121a025

Matsunaga, 1989, Further Kabiramides and Halichondramides, Cytotoxic Macrolides Embracing Trisoxazole, from the Hexabranchus Egg Masses, J. Org. Chem, 54, 1360, 10.1021/jo00267a024

Roesener, 1986, Ulapualide A and B, Extraordinary Antitumor Macrolides from Nudibranch Eggmasses, J. Am. Chem. Soc, 108, 846, 10.1021/ja00264a052

Kerman, 1988, Macrocyclic Antifungal Metabolites from the Spanish Dancer Nudibranch Hexabranchus sanguineus and Sponges of the Genus Halichondria, J. Org. Chem, 53, 5014, 10.1021/jo00256a021

Kobayashi, 1993, Jaspamides A-C, New Cytotoxic Macrolides from the Okinawan Sponge Jaspis sp, J. Nat. Prod, 56, 787, 10.1021/np50095a021

Saito, 1994, Mycalolide B, a Novel Actin Depolymerizing Agent, J. Biol. Chem, 269, 29710, 10.1016/S0021-9258(18)43938-5

Hershko, 1998, The Ubiquitin System, Annu. Rev. Biochem, 67, 425, 10.1146/annurev.biochem.67.1.425

Voges, 1999, The 26S Proteasome: A Molecular Machine Designed for Controlled Proteolysis, Annu. Rev. Biochem, 68, 1015, 10.1146/annurev.biochem.68.1.1015

Pickart, 2001, Mechanisms Underlying Ubiquitination, Annu. Rev. Biochem, 70, 503, 10.1146/annurev.biochem.70.1.503

Glickman, 2002, The Ubiquitin-Proteasome Proteolytic Pathway: Destruction for the Sake of Construction, Physiol. Rev, 82, 373, 10.1152/physrev.00027.2001

Almond, 2002, The Proteasome: A Novel Target for Cancer Chemotherapy, Leukemia, 16, 433, 10.1038/sj.leu.2402417

Rock, 1994, Inhibitors of the Proteasome Block the Degradation of Most Cell Proteins and the Generation of Peptides Presented on MHC Class I Molecules, Cell, 78, 761, 10.1016/S0092-8674(94)90462-6

Adams, 1998, Potent and Selective Inhibitors of the Proteasome: Dipeptidyl Boronic Acids, Bioorg. Med. Chem. Lett, 8, 333, 10.1016/S0960-894X(98)00029-8

Omura, 1991, Lactacysitin, a Novel Microbial Metabolite, Induces Neuritogenesis of Neuroblastoma Cells, J. Antibiotics, 44, 113, 10.7164/antibiotics.44.113

Omura, 1991, Structure of Lactacystin, a New Microbial Metabolite Which Induces Differentiation of Neuroblastoma Cells, J. Antibiotics, 44, 117, 10.7164/antibiotics.44.117

Fenteany, 1994, A β-Lactone Related to Lactacystin Induces Neurite Outgrowth in a Neuroblastoma Cell Line and Inhibits Cell Cycle Progression in a Osteosarcoma Cell Line, Proc. Natl. Acad. Sci. USA, 91, 3358, 10.1073/pnas.91.8.3358

Hanada, 1992, Epoxomicin, a New Antitumor Agent of Microbial Origin, J Antibiotics, 45, 1746, 10.7164/antibiotics.45.1746

Meng, 1999, Epoxomicin, a Potent and Selective Proteasome Inhibitor, Exhibits in vivo Antiinflammatory Activity, Proc. Natl. Acad. Sci. USA, 96, 10403, 10.1073/pnas.96.18.10403

Feling, 2003, Salinosporamide A: A Highly Cytotoxic Proteasome Inhibitor from a Novel Microbial Source, a Marine Bacterium of the New Genus Salinospora, Angew. Chem. Int. Ed, 42, 355, 10.1002/anie.200390115

Kane, 2003, Velcade®: U.S. FDA Approval for the Treatment of Multiple Myeloma Progressing on Prior Therapy, The Oncologist, 8, 508, 10.1634/theoncologist.8-6-508

Ciechanover, 2000, The Ubiquitin-Mediated Proteolytic Pathway: Mode of Action and Clinical Implications, J. Cell. Biochem. Suppl, 34, 40, 10.1002/(SICI)1097-4644(2000)77:34+<40::AID-JCB9>3.0.CO;2-6

Tsukamoto, 2003, New Polyhydroxy Sterols: Proteasome Inhibitors from a Marine Sponge Acanthodendrorilla sp, J. Nat. Prod, 66, 1181, 10.1021/np030120v

Tsukamoto, 2005, Himeic Acid A: A New Ubiquitin-activating Enzyme Inhibitor Isolated from a Marine-derived Fungus, Aspergillus sp, Bioorg. Med. Chem. Lett, 15, 191, 10.1016/j.bmcl.2004.10.012

Tsukamoto, 2004, Girolline, an Antitumor Compound Isolated from a Sponge, Induces G2/M Cell Cycle Arrest and Accumulation of Polyubiquitinated p53, Biol. Pharm. Bull, 27, 699, 10.1248/bpb.27.699

Kobayashi, 1997, New Cytotoxic Oxazole-Containing Metabolites from Okinawan Sponge Halichondria sp, J. Nat. Prod, 60, 150, 10.1021/np960558d

Since secomycalolide A (1) decomposed during storage, 13C NMR spectra could not be measured.